Autolus SVP Alex Driggs reports equity holdings
Autolus Therapeutics plc executive Alex Driggs, SVP Legal Affairs and General Counsel, reports his initial ownership in the company.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Autolus Therapeutics plc executive Alex Driggs, SVP Legal Affairs and General Counsel, reports his initial ownership in the company. He directly holds 18,418 American Depositary Shares, plus multiple share options over ADSs with exercise prices ranging from $1.62 to $29.86 expiring between 2028 and 2036, and 33,000 restricted share units that vest in four equal annual installments starting in 2027.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | American Depositary Shares | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Restricted Share Units | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
Footnotes (10)
- F1. Each American Depositary Share is convertible at any time at the option of the Reporting Person into one Ordinary Share.
- F2. Fully vested and exercisable.
- F3. This option vested 25% on July 22, 2023 and the remainder vests in 36 equal monthly installments thereafter.
- F4. This option vested 25% on March 6, 2024 and the remainder vests in 36 equal monthly installments thereafter.
- F5. This option vested 25% on October 12, 2024 and the remainder vests in 36 equal monthly installments thereafter.
- F6. This option vested 25% on February 23, 2025 and the remainder vests in 36 equal monthly installments thereafter.
- F7. This option vested 25% on March 14, 2026 and the remainder vests in 36 equal monthly installments thereafter.
- F8. This option vests 25% on March 4, 2027 and the remainder vests in 36 equal monthly installments thereafter.
- F9. The restricted share units ("RSUs") vest in four equal annual installments commencing on January 26, 2027.
- F10. Each RSU represents a contingent right to receive one Issuer American Depositary Share.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider position does Alex Driggs hold at Autolus Therapeutics (AUTL)?
How many Autolus Therapeutics (AUTL) ADSs does Alex Driggs directly own?
Do the RSUs and options reported by Alex Driggs in AUTL convert into ADSs?
Does the Autolus Therapeutics (AUTL) Form 3 show any insider buying or selling by Alex Driggs?
AI-generated analysis. How Rhea-AI works. Not financial advice.
